The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR -G542X nonsense allele in a CF mouse model
Open accessAbstract
Nonsense mutations inactivate gene function and are the underlying cause of a large percentage of the individual cases of many genetic disorders. PTC124 is an orally bioavailable compound that promotes readthrough of premature translation termination codons, suggesting that it may have the potential to treat genetic diseases caused by nonsense mutations. Using a mouse model for cystic fibrosis (CF), we show that s.c. injection or oral administration of PTC124 to Cftr −/− mice expressing a human CFTR -G542X transgene suppressed the G542X nonsense mutation and restored a significant amount of human (h)CFTR protein and function. Translational readthrough of the premature stop codon was demonstrated in this mouse model in two ways. First, immunofluorescence staining showed that PTC124 treatment resulted in the appearance of hCFTR protein at the apical surface of intestinal glands in Cftr −/− hCFTR -G542X mice. In addition, functional assays demonstrated that PTC124 treatment restored 24–29% of the average cAMP-stimulated transepithelial chloride currents observed in wild-type mice. These results indicate that PTC124 can effectively suppress the hCFTR -G542X nonsense mutation in vivo . In light of its oral bioavailability, safety toxicology profile in animal studies, and efficacy with other nonsense alleles, PTC124 has the potential to be an important therapeutic agent for the treatment of inherited diseases caused by nonsense mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
PTC124 targets genetic disorders caused by nonsense mutations
Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C. R., Hwang, S., et al. (2007) · Nature · doi:10.1038/nature05756 · Cited by 1,137
Self-citationAn Animal Model for Cystic Fibrosis Made by Gene Targeting
Snouwaert, J. N., Brigman, K. K., Latour, A. M., Malouf, N. N., Boucher, R. C., Smithies, O., & Koller, B. H. (1992) · Science · doi:10.1126/science.257.5073.1083 · Cited by 918
Aminoglycosides: Nephrotoxicity
Mingeot-Leclercq, M.-P., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1003 · Cited by 757
Wilschanski, M., Yahav, Y., Yaacov, Y., Blau, H., Bentur, L., Rivlin, J., Aviram, M., Bdolah-Abram, T., Bebok, Z., Shushi, L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022170 · Cited by 503
Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations
Howard, M., Frizzell, R. A., & Bedwell, D. M. (1996) · Nature Medicine · doi:10.1038/nm0496-467 · Cited by 493
Self-citationMANUVAKHOVA, M., KEELING, K., & BEDWELL, D. M. (2000) · RNA · doi:10.1017/s1355838200000716 · Cited by 404
Self-citationCulbertson, M. R. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01658-8 · Cited by 396
The Phenotypic Consequences of CFTR Mutations
Rowntree, R. K., & Harris, A. (2003) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2003.00028.x · Cited by 346
Koerner, T. J., Hill, J. E., Myers, A. M., & Tzagoloff, A. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)94036-c · Cited by 343
Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line
Bedwell, D. M., Kaenjak, A., Benos, D. J., Bebok, Z., Bubien, J. K., Hong, J., Tousson, A., Clancy, J. P., & Sorscher, E. J. (1997) · Nature Medicine · doi:10.1038/nm1197-1280 · Cited by 343
Self-citationPopulation variation of common cystic fibrosis mutations
The Cystic Fibrosis Genetic Analysis Consortium (1994) · Human Mutation · doi:10.1002/humu.1380040302 · Cited by 309
Bonetti, B., Fu, L., Moon, J., & Bedwell, D. M. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0438 · Cited by 307
Self-citationEarly nonsense: mRNA decay solves a translational problem
Amrani, N., Sachs, M. S., & Jacobson, A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1942 · Cited by 286
CLANCY, J. P., BEBÖK, Z., RUIZ, F., KING, C., JONES, J., WALKER, L., GREER, H., HONG, J., WING, L., MACALUSO, M., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2004001 · Cited by 253
Self-citationHirawat, S., Welch, E. M., Elfring, G. L., Northcutt, V. J., Paushkin, S., Hwang, S., Leonard, E. M., Almstead, N. G., Ju, W., Peltz, S. W., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006297140 · Cited by 242
Self-citationWILSCHANSKI, M., FAMINI, C., BLAU, H., RIVLIN, J., AUGARTEN, A., AVITAL, A., KEREM, B., & KEREM, E. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9904116 · Cited by 212
Du, M., Jones, J. R., Lanier, J., Keeling, K. M., Lindsey, R. J., Tousson, A., Bebök, Z., Whitsett, J. A., Dey, C. R., Colledge, W. H., et al. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0363-1 · Cited by 181
Self-citationKeeling, K. M., & Bedwell, D. M. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0317-z · Cited by 155
Self-citationNa and Cl transport across the isolated turtle colon: Parallel pathways for transmural ion movement
Dawson, D. C. (1977) · The Journal of Membrane Biology · doi:10.1007/bf01940933 · Cited by 110
Du, M., Keeling, K. M., Fan, L., Liu, X., Kovács, T., Sorscher, E. J., & Bedwell, D. M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0045-5 · Cited by 83
Self-citationZsembery, Á., Jessner, W., Sitter, G., Spirlì, C., Strazzabosco, M., & Graf, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30423 · Cited by 56
Cited by
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
Veit, G., Avramescu, R. G., Chiang, A. N., Houck, S. A., Cai, Z., Peters, K. W., Hong, J. S., Pollard, H. B., Guggino, W. B., Balch, W. E., et al. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0935 · Cited by 580
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Ataluren treatment of patients with nonsense mutation dystrophinopathy
Bushby, K., Finkel, R., Wong, B., Barohn, R., Campbell, C., Comi, G. P., Connolly, A. M., Day, J. W., Flanigan, K. M., Goemans, N., et al. (2014) · Muscle & Nerve · doi:10.1002/mus.24332 · Cited by 428
Self-citation
Metadata
- Authors
- Du, M., Liu, X., Welch, E. M., Hirawat, S., Peltz, S. W., & Bedwell, D. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-02-12
- Volume
- 105
- Issue
- 6
- Pages
- 2064-2069
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1988397255
- Cited by
- 256
- References
- 22
- FWCI
- 20.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.